Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Peripheral Stem Cell/Marrow Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00025662
What this trial is testing

Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS

Who this might be right for
Graft vs Host DiseaseMyelodysplastic SyndromesLeukemia+7 more
National Heart, Lung, and Blood Institute (NHLBI) 23
Not applicableLooking for participantsNCT06856226
What this trial is testing

Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

Who this might be right for
LeukemiaLymphomaHematologic Malignancy
National Cancer Institute (NCI) 88
Large-scale testing (Phase 3)Ended earlyNCT00003056
What this trial is testing

Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaGraft Versus Host Disease
Baxalta now part of Shire 105
Testing effectiveness (Phase 2)Study completedNCT00004231
What this trial is testing

Combination Chemotherapy, Bone Marrow or Peripheral Stem Cell Transplantation, and/or Biological Therapy in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma

Who this might be right for
Lymphoma
Northwestern University
Testing effectiveness (Phase 2)Study completedNCT00002522
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Temple University
Not applicableEnded earlyNCT00813501
What this trial is testing

Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseInfection+7 more
City of Hope Medical Center 60
Testing effectiveness (Phase 2)Study completedNCT00064311
What this trial is testing

Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
National Institutes of Health Clinical Center (CC)
Large-scale testing (Phase 3)Study completedNCT00406393
What this trial is testing

Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402)

Who this might be right for
Leukemia, Myelocytic, AcuteLeukemia, Lymphocytic, AcuteLeukemia, Myeloid, Chronic+1 more
Medical College of Wisconsin 304
Not applicableStudy completedNCT00010361
What this trial is testing

Study of Total Body Irradiation and Fludarabine Followed By Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation in Combination With Cyclosporine and Mycophenolate Mofetil in Patients With Inherited Disorders

Who this might be right for
Metabolism, Inborn ErrorsGranulomatous Disease, Chronic
Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00054327
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Case Comprehensive Cancer Center 34
Testing effectiveness (Phase 2)Ended earlyNCT00005986
What this trial is testing

Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Masonic Cancer Center, University of Minnesota
Testing effectiveness (Phase 2)Ended earlyNCT02127892
What this trial is testing

SCID Bu/Flu/ATG Study With T Cell Depletion

Who this might be right for
Severe Combined Immunodeficiency
Neena Kapoor, M.D. 9
Testing effectiveness (Phase 2)Study completedNCT00004907
What this trial is testing

Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Northwestern University
Testing effectiveness (Phase 2)Study completedNCT00105001
What this trial is testing

Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Myelodysplastic/Myeloproliferative Neoplasm, UnclassifiablePreviously Treated Myelodysplastic SyndromeRefractory Chronic Lymphocytic Leukemia+113 more
Fred Hutchinson Cancer Center 210
Testing effectiveness (Phase 2)Study completedNCT00619645
What this trial is testing

Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of California, Davis 8
Testing effectiveness (Phase 2)Study completedNCT00003145
What this trial is testing

Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia

Who this might be right for
Accelerated Phase of DiseaseChildhood Chronic Myelogenous Leukemia, BCR-ABL1 PositiveChronic Myelogenous Leukemia, BCR-ABL1 Positive+2 more
Fred Hutchinson Cancer Center 18
Not applicableStudy completedNCT01378182
What this trial is testing

Efficacy of Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cell Transplantation Via Portal Vein or Hepatic Artery or Peripheral Vein in Patients With Wilson Cirrhosis

Who this might be right for
Wilson's Disease
Murat Kantarcioglu 10
Early research (Phase 1)Study completedNCT00007891
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Cancer Research Institute of Contra Costa
Testing effectiveness (Phase 2)Study completedNCT00467961
What this trial is testing

Stem Cell Transplantation for Patients With Cancers of the Blood

Who this might be right for
CML (Chronic Myelogenous Leukemia)CLL (Chronic Lymphocytic Leukemia)AML (Acute Myelogenous Leukemia)+2 more
National Heart, Lung, and Blood Institute (NHLBI) 61
Early research (Phase 1)Study completedNCT00003081
What this trial is testing

Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma

Who this might be right for
Sarcoma
Fred Hutchinson Cancer Center 16
Next Page